Search

everythinglearnresearchcommunity

for

Search:↓

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

The document describes the signs of different common types of hair loss.

Hair proteins in preschool children and their mothers could indicate developmental changes and health status.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Hair loss can significantly impact a person's mental health, causing issues like anxiety and depression, and stress can trigger hair loss.

A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Most Recessive Dystrophic Epidermolysis Bullosa patients with a specific mutation likely have Sephardic ancestry from about 500 years ago.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

Skin grafts from related donors significantly healed chronic wounds in patients with a severe skin condition over a year.

Corkscrew hair may be a new sign for quickly diagnosing scalp fungus in black children.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

The document concludes that certain rats and mice are useful for studying hair loss in humans and testing treatments.

Thallium poisoning can cause severe neurological symptoms and hair loss.

Chemotherapy affects blood vessels in hair follicles, not stem cells, allowing hair regrowth.

Cyclosporine A slows down hair loss from chemotherapy in mice, while dexamethasone increases hair loss but speeds up regrowth.

Trichoscopy effectively diagnoses eyebrow loss, distinguishing between alopecia areata and frontal fibrosing alopecia.

Some people with heavy hair shedding might actually have a hidden form of alopecia, which can be identified by specific hair changes.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Lithium treatment can cause increased hair shedding and hair loss in patients.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.